90 related articles for article (PubMed ID: 3335030)
1. In vivo 31P nuclear magnetic resonance spectroscopy of subcutaneous 9L gliosarcoma: effects of tumor growth and treatment with 1,3-bis(2-chloroethyl)-1-nitrosourea on tumor bioenergetics and histology.
Steen RG; Tamargo RJ; McGovern KA; Rajan SS; Brem H; Wehrle JP; Glickson JD
Cancer Res; 1988 Feb; 48(3):676-81. PubMed ID: 3335030
[TBL] [Abstract][Full Text] [Related]
2. In vivo 31P nuclear magnetic resonance spectroscopy of subcutaneous 9L gliosarcoma: effects of tumor growth and treatment with 1,3-bis(2-chloroethyl)-1-nitrosourea on tumor bioenergetics and histology.
Sijens PE; Bovee WM
Cancer Res; 1988 Oct; 48(19):5610-1. PubMed ID: 3416313
[No Abstract] [Full Text] [Related]
3. Effects of chemotherapy by 1,3-bis(2-chloroethyl)-1-nitrosourea on single-quantum- and triple-quantum-filtered 23Na and 31P nuclear magnetic resonance of the subcutaneously implanted 9L glioma.
Winter PM; Poptani H; Bansal N
Cancer Res; 2001 Mar; 61(5):2002-7. PubMed ID: 11280759
[TBL] [Abstract][Full Text] [Related]
4. Growth kinetics and treatment response of the intracerebral rat 9L brain tumor model: a quantitative in vivo study using magnetic resonance imaging.
Kim B; Chenevert TL; Ross BD
Clin Cancer Res; 1995 Jun; 1(6):643-50. PubMed ID: 9816027
[TBL] [Abstract][Full Text] [Related]
5. Measurements of in vivo 31P nuclear magnetic resonance spectra in neuroectodermal tumors for the evaluation of the effects of chemotherapy.
Naruse S; Hirakawa K; Horikawa Y; Tanaka C; Higuchi T; Ueda S; Nishikawa H; Watari H
Cancer Res; 1985 Jun; 45(6):2429-33. PubMed ID: 3986784
[TBL] [Abstract][Full Text] [Related]
6. Monitoring early response of experimental brain tumors to therapy using diffusion magnetic resonance imaging.
Chenevert TL; McKeever PE; Ross BD
Clin Cancer Res; 1997 Sep; 3(9):1457-66. PubMed ID: 9815831
[TBL] [Abstract][Full Text] [Related]
7. In vivo 31P nuclear magnetic resonance spectroscopy of rat 9L gliosarcoma treated with BCNU: dose response of spectral changes.
Steen RG; Tamargo RJ; Brem H; Glickson JD; Wehrle JP
Magn Reson Med; 1989 Aug; 11(2):258-66. PubMed ID: 2779416
[TBL] [Abstract][Full Text] [Related]
8. Sensitization of 9L rat brain gliosarcoma cells to 1,3-bis(2-chloroethyl)-1-nitrosourea by alpha-difluoromethylornithine, an ornithine decarboxylase inhibitor.
Hung DT; Deen DF; Seidenfeld J; Marton LJ
Cancer Res; 1981 Jul; 41(7):2783-5. PubMed ID: 6788362
[TBL] [Abstract][Full Text] [Related]
9. Response of radiation-induced fibrosarcoma-1 in mice to cyclophosphamide monitored by in vivo 31P nuclear magnetic resonance spectroscopy.
Li SJ; Wehrle JP; Rajan SS; Steen RG; Glickson JD; Hilton J
Cancer Res; 1988 Sep; 48(17):4736-42. PubMed ID: 3409214
[TBL] [Abstract][Full Text] [Related]
10. Predicting and monitoring response to chemotherapy by 1,3-bis(2-chloroethyl)-1-nitrosourea in subcutaneously implanted 9L glioma using the apparent diffusion coefficient of water and 23Na MRI.
Babsky AM; Hekmatyar SK; Zhang H; Solomon JL; Bansal N
J Magn Reson Imaging; 2006 Jul; 24(1):132-9. PubMed ID: 16758478
[TBL] [Abstract][Full Text] [Related]
11. In vivo 31P MRS in new antineoplastic agents evaluation on experimental tumor models.
Le Moyec L; Naruse S; Higuchi T; Hirakawa K; Watari H; de Certaines JD; Roques BP
Cancer Biochem Biophys; 1988 Jul; 10(1):31-45. PubMed ID: 2465078
[TBL] [Abstract][Full Text] [Related]
12. 31P-nuclear magnetic resonance studies of the effect of recombinant human interleukin 1 alpha on the bioenergetics of RIF-1 tumors.
Constantinidis I; Braunschweiger PG; Wehrle JP; Kumar N; Johnson CS; Furmanski P; Glickson JD
Cancer Res; 1989 Nov; 49(22):6379-82. PubMed ID: 2804984
[TBL] [Abstract][Full Text] [Related]
13. 31P magnetic resonance spectroscopy is sensitive to tumor hypoxia: perfusion and oxygenation of rat 9L gliosarcoma after treatment with BCNU.
Steen RG; Graham MM
NMR Biomed; 1991 Jun; 4(3):117-24. PubMed ID: 1911098
[TBL] [Abstract][Full Text] [Related]
14. 31P-nuclear magnetic resonance spectroscopy studies of the response of rat mammary tumors to endocrine therapy.
Rodrigues LM; Midwood CJ; Coombes RC; Stevens AN; Stubbs M; Griffiths JR
Cancer Res; 1988 Jan; 48(1):89-93. PubMed ID: 3335001
[TBL] [Abstract][Full Text] [Related]
15. In vivo 31P-nuclear magnetic resonance study of the response of a murine mammary tumor to different doses of gamma-radiation.
Sijens PE; Bovée WM; Seijkens D; Los G; Rutgers DH
Cancer Res; 1986 Mar; 46(3):1427-32. PubMed ID: 3943104
[TBL] [Abstract][Full Text] [Related]
16. Intrathecal chemotherapy with 1,3-bis(2-chloroethyl)-1-nitrosourea encapsulated into hybrid liposomes for meningeal gliomatosis: an experimental study.
Kitamura I; Kochi M; Matsumoto Y; Ueoka R; Kuratsu J; Ushio Y
Cancer Res; 1996 Sep; 56(17):3986-92. PubMed ID: 8752168
[TBL] [Abstract][Full Text] [Related]
17. Combination therapy with 1,3-bis(2-chloroethyl)-1-nitrosourea and low dose rate radiation in the 9L rat brain tumor and spheroid models: implications for brain tumor brachytherapy.
Gutin PH; Bernstein M; Sano Y; Deen DF
Neurosurgery; 1984 Dec; 15(6):781-6. PubMed ID: 6514150
[TBL] [Abstract][Full Text] [Related]
18. Effects of alpha-difluoromethylornithine on the growth of 9L rat brain tumor multicellular spheroids and their response to 1,3-bis(2-chloroethyl)-1-nitrosourea.
Sano Y; Deen DF; Oredsson SM; Marton LJ
Cancer Res; 1984 Feb; 44(2):577-81. PubMed ID: 6420048
[TBL] [Abstract][Full Text] [Related]
19. Cell cycle age response of 9L cells to 1,3-bis(2-chloroethyl)-1-nitrosourea and modification by alpha-difluoromethylornithine.
Bjerkvig R; Oredsson SM; Marton LJ; Linden M; Deen DF
Cancer Res; 1983 Apr; 43(4):1497-500. PubMed ID: 6403224
[TBL] [Abstract][Full Text] [Related]
20. High glycolytic activity in rat glioma demonstrated in vivo by correlation peak 1H magnetic resonance imaging.
Ziegler A; von Kienlin M; Décorps M; Rémy C
Cancer Res; 2001 Jul; 61(14):5595-600. PubMed ID: 11454713
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]